SPRR1A and cancer: However, our in vitro study showed that SPRR1A overexpression in both PK-1 (expressing SPRR1A) and Panc-1 (not expressing SPRR1A) did not affect the phenotype, such as cell proliferation, chemo-resistance, EMT and migration ability, all of which are associated with aggressive behavior in cancers.